224 related articles for article (PubMed ID: 2154433)
1. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Maskell JP; Sefton AM; Williams JD
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Dunkin KT; Jones S; Howard AJ
J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
[TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD
Infection; 1988; 16(6):365-70. PubMed ID: 3146552
[TBL] [Abstract][Full Text] [Related]
4. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Rospide MF; Biedenbach DJ; Jones RN
Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
[TBL] [Abstract][Full Text] [Related]
5. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
Maskell JP; Tang T; Asad S; Williams JD
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():65-74. PubMed ID: 2732145
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of the new oral macrolide azithromycin.
Neu HC; Chin NX; Saha G; Labthavikul P
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):541-4. PubMed ID: 2846300
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):230-5. PubMed ID: 10367484
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of RU-66647, a new ketolide.
Jones RN; Biedenbach DJ
Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of A-56268.
Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
Yu KW; Neu HC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1839-42. PubMed ID: 2126695
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
[TBL] [Abstract][Full Text] [Related]
14. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Wise R; Brenwald NP; Andrews JM; Boswell F
J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816
[TBL] [Abstract][Full Text] [Related]
15. Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Feb; 38(2):211-6. PubMed ID: 8192445
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
[TBL] [Abstract][Full Text] [Related]
17. Influence of the test medium on azithromycin and erythromycin regression statistics.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):846-9. PubMed ID: 1662629
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
Jamjian C; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Fass RJ
Antimicrob Agents Chemother; 1993 Oct; 37(10):2080-6. PubMed ID: 8257127
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]